Si-

Masato Shimada1, Yoshihisa Koyama2,3,4,5, Yuki Kobayashi6

  • 1Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Scientific reports
|February 20, 2024
PubMed
概括

一种基于的新型抗氧化剂有效地治疗小肠道缺血-再输液 (IR) 损伤. 这种药物减少了细胞死亡,并保持了肠粘膜的厚度,为改善移植结果提供了潜在的机会.